For laboratory research only
Compare Semax research suppliers
Listings now default to lowest tracked price per mg. The highlighted price badge is a catalog-price signal only, not a quality, safety, or documentation ranking.
The document count covers six basic checks. “Not found” means we could not confirm it from the public records we reviewed—not that the testing never happened.
Affiliate disclosure: Some links may earn PDD a commission. Affiliate status does not change what we report or how suppliers are ordered.
Eppix Labs
5 of 6 fields documentedReview recommendedSemax (10 mg)
Exact name catalog match · No active affiliate relationship · Price badge is not an overall recommendation
Listed price
$25.99
$2.60 per mg
In stock
Particle Peptides
2 of 6 fields documentedReview recommendedSemax (10 mg)
Exact name catalog match · Affiliate relationship · Price badge is not an overall recommendation
Listed price
€32.51
€3.25 per mg
In stock
Elite Research Labs
6 of 6 fields documentedChecked 12 days agoSemax (10 mg)
Exact name catalog match · Affiliate relationship
Listed price
$33.99
$3.40 per mg
In stock
PS Peptides
5 of 6 fields documentedPossibly outdatedSemax (11 mg)
Exact name catalog match · Affiliate relationship
Listed price
$42.99
$3.91 per mg
Est. with PDD10: $38.69
$3.52/mg
In stock
Arizen BioLabs
1 of 6 fields documentedPossibly outdatedSemax (10 mg)
Exact name catalog match · Affiliate relationship
Listed price
$39.99
$4.00 per mg
Est. with PDD10: $35.99
$3.60/mg
In stock
How Semax is used in research
Semax combines an ACTH(4–7)-related sequence with a Pro-Gly-Pro segment. Experimental studies have examined neurotrophic signaling, oxidative stress, inflammatory pathways, and behavioral or ischemia-related endpoints.
Human literature exists but is regionally concentrated and does not establish FDA approval or equivalence for online research materials.
Evidence map
Research stage matters. Findings from one model should not be silently promoted to another.
Laboratory
Molecular studies examine gene expression and trophic signaling.
Animal
Rodent behavioral and cerebral-ischemia models are prominent.
Human
Limited clinical literature exists outside a broad U.S. regulatory review framework.
What the evidence does not establish
Heterogeneous methods, language accessibility, and limited large independent trials restrict clinical inference.
Study findings also do not authenticate a supplier’s material. Biological plausibility, a familiar name, or a published paper cannot substitute for lot-specific identity and quality evidence.
Analytical and documentation checks
The test plan should match the exact molecule, modification, and research question.
- Confirm the exact ACTH-fragment analog sequence.
- Assess identity and degradation because small peptides can produce related fragments.
- Separate biological-activity assays from chemical-purity measurements.
At minimum, connect the product name, sequence, sample identifier, lot, report, method, expected result, and observed result. Record untested attributes as “not reported,” not as assumed passes.
Build the documentation record
Regulatory status
Semax is not an FDA-approved drug.
Regulatory status can change and attaches to specific products and jurisdictions. Verify current official records before publishing, procuring, or relying on a status claim.
Primary sources and official records
Use these records as starting points, then assess the exact model, test article, methods, and date:
Peptide Due Diligence Research Brief
Follow the evidence, not the headline.
Receive new evidence maps, documentation guides, and material corrections as the directory expands.
By subscribing, you agree to receive PDD research emails. Unsubscribe at any time.
Already subscribed? Get your free checklist.